San Juan, Puerto Rico – John F. Crowley, CEO of the Biotechnology Innovation Organization (BIO), concluded a visit to Puerto Rico on Thursday, signaling a renewed focus on the island’s potential within the United States biomanufacturing sector. The visit, Crowley’s first to Puerto Rico, underscored the organization’s assessment of the island as a strategically important location for attracting investment.
Crowley’s visit and subsequent statements mark a shift in momentum for Puerto Rico’s biomanufacturing industry, according to reports from El Nuevo Día. The renewed interest comes as the United States seeks to bolster domestic biomanufacturing capabilities. BIO’s assessment highlights Puerto Rico’s potential to play a significant role in that effort.
Details of Crowley’s meetings and specific investment proposals were not immediately disclosed. However, the Biotechnology Innovation Organization’s public acknowledgement of Puerto Rico’s strategic value represents a notable development for the island’s economic future. A post on the Facebook page of the Department of Economic Development and Commerce of Puerto Rico (DDECPR) highlighted Crowley’s statement: “Puerto Rico vuelve al juego de la biomanufactura.”
The timing of Crowley’s visit and BIO’s statement aligns with increasing discussion surrounding the resilience of U.S. Supply chains and the need for geographically diverse manufacturing hubs. Puerto Rico’s existing infrastructure and skilled workforce position it as a potentially attractive location for biomanufacturing companies seeking to expand or relocate operations.
As of Friday, March 13, 2026, BIO has not released a detailed report outlining specific recommendations or investment targets for Puerto Rico. Further announcements regarding potential collaborations or initiatives are expected in the coming weeks.
